NCT06124586 - Early Percutaneous Transluminal Angioplasty in Diabetic Foot Syndrome (PTA-DFS) | Biotech Hunter

Enrollment

200

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

February 1, 2028

Study Completion Date

November 1, 2028

Conditions

Diabetic FootDiabetes MellitusPeripheral Arterial DiseaseDiabetic NeuropathiesDiabetic RetinopathyAnemiaUlcer FootUlcer IschemicDiabetic Polyneuropathy

Interventions

PROCEDURE

Percutaneous transluminal angioplasty

Percutaneous transluminal angioplasty of the leg

Trial Locations (1)

40225

RECRUITING

University-Hospital Düsseldorf Division of Cardiology, Pulmonary Disease and Vascular Medicine, Düsseldorf